Clinical Trials Browser

Phase 1/2 × Stomach Neoplasms × Sorafenib × Clear all

NCT00565370 2020-01-18

Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XP

Phase 1/2 Completed

22 enrolled 11 charts

Gastrointestinal

Stomach Neoplasms